This article summarises the key breakthroughs in the treatment of renal cell carcinoma (RCC) in 2020, including a new first-line VEGF-TKI and immunotherapy combination (cabozantinib plus nivolumab) and immunotherapy as a new standard of treatment for patients with nonâclear cell RCC and sarcomatoid RCC.
Read more in Practice Update here
The post 2020 top stories in kidney cancer appeared first on Kidney Cancer Support Network.